Testing effectiveness (Phase 2)UnknownNCT00876902
What this trial is testing
YSPSL for Prevention of Ischemic Reperfusion Injury in Patients Undergoing Cadaveric Orthotopic Liver Transplantation
Who this might be right for
Ischemia Reperfusion Injury
Y's Therapeutics, Inc. 36